Getwell Pharma India Private Limited — Paclitaxel Exporter Profile
Indian Pharmaceutical Exporter · #12 for Paclitaxel · $1.7M export value · DGFT Verified
Getwell Pharma India Private Limited is the #12 Indian exporter of Paclitaxel with $1.7M in export value and 106 verified shipments. Getwell Pharma India Private Limited holds a 2.0% market share in Paclitaxel exports across 11 countries. The company exports 10 pharmaceutical products worth $4.6M across 3 therapeutic categories.
Getwell Pharma India Private Limited — Paclitaxel Export Profile: Buyers & Destinations
Where Does Getwell Pharma India Private Limited Export Paclitaxel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GEORGIA | $974.5K | 23 | 65.6% |
| PHILIPPINES | $117.9K | 4 | 7.9% |
| JAMAICA | $102.9K | 25 | 6.9% |
| MYANMAR | $64.4K | 22 | 4.3% |
| KENYA | $61.9K | 33 | 4.2% |
| NEPAL | $41.6K | 10 | 2.8% |
| MAURITIUS | $36.1K | 25 | 2.4% |
| SEYCHELLES | $29.1K | 4 | 2.0% |
| TRINIDAD AND TOBAGO | $25.3K | 3 | 1.7% |
| MOZAMBIQUE | $12.6K | 2 | 0.8% |
Getwell Pharma India Private Limited exports Paclitaxel to 14 countries. The largest destination is GEORGIA accounting for 65.6% of Getwell Pharma India Private Limited's Paclitaxel shipments, followed by PHILIPPINES (7.9%) and JAMAICA (6.9%). These destinations reflect Getwell Pharma India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Paclitaxel from Getwell Pharma India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MERMISI LLC | GEORGIA | $974.5K | 23 |
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $117.9K | 4 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $102.9K | 25 |
| PHARMAFORTE COMPANY LIMITED | MYANMAR | $50.4K | 17 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $29.2K | 15 |
| HEALTH CARE AGENCY | SEYCHELLES | $29.1K | 4 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $28.3K | 6 |
| THE MAURITIUS PHARMACY (SEEGOBIN) | MAURITIUS | $25.8K | 19 |
| SUNCREST INTERNATIONAL LIMITED | TRINIDAD AND TOBAGO | $25.3K | 2 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $17.7K | 9 |
Getwell Pharma India Private Limited supplies Paclitaxel to 29 buyers globally. The largest buyer is MERMISI LLC (GEORGIA), followed by AMBICA INTERNATIONAL CORPORATION (PHILIPPINES) and RECHARGED DISTRIBUTORS LIMITED (JAMAICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Paclitaxel Export Value and How Much Does Getwell Pharma India Private Limited Contribute?
India exported $61.4M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. Getwell Pharma India Private Limited contributes $1.7M to this total, accounting for 2.0% of India's Paclitaxel exports. Getwell Pharma India Private Limited ships Paclitaxel to 14 countries through 29 buyers.
What Is the Average Shipment Value for Getwell Pharma India Private Limited's Paclitaxel Exports?
Getwell Pharma India Private Limited's average Paclitaxel shipment value is $15.8K per consignment, based on 106 shipments totaling $1.7M. The largest destination is GEORGIA (65.6% of Getwell Pharma India Private Limited's Paclitaxel exports).
How Does Getwell Pharma India Private Limited Compare to Other Indian Paclitaxel Exporters?
Getwell Pharma India Private Limited ranks #12 among 319 Indian Paclitaxel exporters with a 2.0% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($25.1M), MSN LABORATORIES PRIVATE LIMITED ($6.9M), INTAS PHARMACEUTICALS LIMITED ($5.9M). Getwell Pharma India Private Limited processed 106 shipments to 11 destination countries.
What Paclitaxel Formulations Does Getwell Pharma India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND | $517.0K | 12 |
| PACLIWEL-300MG/50ML (PACLITAXEL INJECTIO | $52.7K | 14 |
| ALPAXEL 100MG (PACLITAXEL(PROTEIN BOUNDPARTICLES)FOR INJECTABLE SUSPENSION)B.NO.4GPNL03, MFG.DT. 04/2024,EXP DT.03/2026 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.4GPNL04MFG.DT.05/2024 EXP.DT.04/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.4GPNL05 MFG.DT.05/24EXP.DT.04/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL (PROTEIN BOUNDPARTICLES) FOR INJECTABLE SUSPENSION)BATCH- 5GPNL01, MFG.DT. 01/25,EXP.DT. 12/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL (PROTEIN BOUNDPARTICLES) FOR INJECTABLE SUSPENSION)BATCH-5GPNL02, MFG.DT. 01/25,EXP.DT. 12/26 | $50.0K | 1 |
| PACLINANO 100MG (PACLITAXEL (PROTEIN-BOUND PARTICLES) FOR INJ. SUSPENSION) BATCH NO. 5GPNL03, MFG.DT. 02/2025, EXP 01/27 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.5GPNL04,MFG.DT.02/2025,EXP.DT.01/27 | $50.0K | 1 |
| ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND PARTICLES) FOR INJECTABLE SUSPENSION) B.: 5GPNL05 M.: 02/2025 E.: 01/2027 | $50.0K | 1 |
Getwell Pharma India Private Limited exports 91 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND with 12 shipments worth $517.0K.
How Does Getwell Pharma India Private Limited Compare to Nearest Paclitaxel Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | ALEMBIC PHARMACEUTICALS LIMITED | $2.2M | 44 | 1 | $50.0K |
| 10 | EUGIA PHARMA SPECIALITIES LIMITED | $2.1M | 88 | 1 | $23.8K |
| 12 | GETWELL PHARMA INDIA PRIVATE LIMITED ★ | $1.7M | 106 | 11 | $15.8K |
| 7 | ACCURE LABS PRIVATE LIMITED | $1.6M | 33 | 1 | $50.0K |
| 13 | SP ACCURE LABS PRIVATE LIMITED | $1.3M | 66 | 9 | $19.0K |
Getwell Pharma India Private Limited ranks #12 among 319 Indian Paclitaxel exporters. Average shipment value of $15.8K compared to the market average of $192.6K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Paclitaxel Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 830 | 16.8% |
| SAHAR AIR | 614 | 12.5% |
| DELHI AIR | 599 | 12.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 554 | 11.2% |
| HYDERABAD AIR | 186 | 3.8% |
| AHEMDABAD AIR | 183 | 3.7% |
| Bombay Air | 172 | 3.5% |
| HYDERABAD ACC (INHYD4) | 160 | 3.2% |
What Other Oncology Products Does Getwell Pharma India Private Limited Export?
Getwell Pharma India Private Limited also exports these oncology products. Each links to the detailed product page.
About Getwell Pharma India Private Limited
Getwell Pharma India Private Limited exports 10 products worth $4.6M. Beyond Paclitaxel, top products include Protein, Doxorubicin, Gemcitabine, Fluorouracil, Cyclophosphamide. View the complete Getwell Pharma India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharma India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 158 individual customs records matching Getwell Pharma India Private Limited exporting Paclitaxel, covering 91 formulations to 14 countries via 29 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Export Data from Getwell Pharma India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharma India Private Limited's Paclitaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharma India Private Limited
Full Company Profile →
10 products · $4.6M total trade · 3 categories
Paclitaxel Stats
Company Overview
Top Products by Getwell Pharma India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharma India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current shipment-level data, contact TransData Nexus.